-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

112. Thalassemia and Globin Gene Regulation: Poster II

Thalassemia and Globin Gene Regulation Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 4, 2016: 6:00 PM-8:00 PM
Hall GH (San Diego Convention Center)

Daniel Garcia-Santos, PhD1*, Amel Hamdi, PhD1, Zuzana Zidova, MSc2*, Monika Horvathova, PhD3 and Prem Ponka, MD, PhD, FCMA1

1Lady Davis Institute for Medical Research, Montreal, QC, Canada
2Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
3Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic

Nianhang Chen1*, Abderrahmane Laadem, MD1, Dawn M. Wilson2*, Xiaosha Zhang2*, Matthew L. Sherman, MD2, Steve Ritland1* and Kenneth M. Attie, MD2

1Celgene Corporation, Summit, NJ
2Acceleron Pharma, Cambridge, MA

Jaira F. de Vasconcellos*, Colleen Byrnes*, Y. Terry Lee*, Pauline C. Xu*, Antoinette Rabel* and Jeffery L. Miller

Molecular Genomics and Therapeutics Section, Genetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD

Thomas M Ryan, PhD*, Suean Daimia Fontenard, BS*, Shanrun Liu, MD, PhD*, Jonathan Lockhart, BS* and Michael Berlett, BS*

University of Alabama at Birmingham, Birmingham, AL

Raffaella Origa1*, Antonio Piga, MD2, Immacolata Tartaglione, MD3*, Giuseppina Della Corte4*, Ali El-Ali5*, Jackie Han6*, Chiara Castiglioni7* and Gian Luca Forni, MD8*

1Ospedale Pediatrico Microcitemico ‘A.Cao’, University of Cagliari, Cagliari, Italy
2Centre for Microcitemie, S Luigi Gonzaga Hospital, University of Turin, Turin, Italy
3Second University of Naples, Naples, Italy
4Ca Granda Foundation IRCCS, Università di Milano, Milan, Italy
5Novartis Pharma AG, Basel, Switzerland
6Novartis Pharmaceuticals, East Hanover, NJ
7Novartis Farma SpA, Origgio, Italy
8Hospital Galliera, Genoa, Italy

Carla Casu1*, Vania Lo Presti1*, Emir M O'Hara1*, Garry Neil2*, Reem Miari3*, Nir Shapir3* and Stefano Rivella, PhD4

1Children’s Hospital of Philadelphia (CHoP), Philadelphia, PA
2Medgenics, Inc, Wayne, PA
3Medgenics Medical Israel, Ltd, Misgav, Israel
4Children's Hospital of Philadelphia, Philadelphia, PA

Farah O'Boyle, PhD1*, Leena Karnik, MD, FRCPath, MBBS,1*, Anne Bradshaw2*, Richard M Szydlo2* and Josu de la Fuente, PhD, FRCP, FRCPI, FRCPCH, FRCPath1,3

1Department of Paediatrics, Imperial College Healthcare NHS Trust, London, United Kingdom
2Centre for Haematology, Imperial College London at Hammersmith Hospital, London, United Kingdom
3Centre for Haematology, Imperial College London, London, United Kingdom

Francesca Vinchi, PhD1*, Gregory M Vercellotti, MD2, John D. Belcher, PhD2, Eitan Fibach, PhD3, Hala Zreid, MD4*, Rushdy Rasras5*, Hussam Ghoti, MD6*, Martina U. Muckenthaler, PhD7 and Eliezer A. Rachmilewitz, MD8

1Department of Pediatric Oncology, Hematology, Immunology and Pulmunology, University of Heidelberg, Molecular Medicine Partnership Unit, Heidelberg, Germany
2Department of Medicine, Division of Hematology, Oncology and Transplantation, Vascular Biology Center, University of Minnesota, Minneapolis, MN
3Department of Hematology, The Hebrew University - Hadassah Medical Center, Jerusalem, Israel
4Department of internal Medicine, Al- Shifa hospital, Gaza, Palestine, State of
5Laboratory department, European Hospital of Gaza, Gaza, Palestine, State of
6Department of Hematology, Assuta Medical Center, Tel -Aviv, Israel
7Department of Pediatric Oncology, Hematology, and Immunology, University of Heidelberg, Heidelberg, Germany
8The Edith Wolfson Medical Center, Holon, Israel

Elliott Vichinsky1, Amal El-Beshlawy2*, Azzam Alzoebie3*, Annie Kamdem, MD4*, Suzanne Koussa5*, Thirachit Chotsampancharoen6*, Andreas Bruederle7*, Jackie Han8* and Mohsen Elalfy9*

1Children's Hospital & Research Center, Oakland
2Cairo University, Cairo, Egypt
3Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates
4Pediatrics, Reference Center for Sickle Cell Disease, CHIC Hospital, Créteil, France
5Chronic Care Center, Hazmieh, Lebanon
6Songklanagarind Hospital, Songkhla, Thailand
7Novartis Pharma AG, Basel, Switzerland
8Novartis Pharmaceuticals, East Hanover, NJ
9Ain Shams University, Cairo, Egypt

Sotirios Bristogiannis, MD1*, Antonios Kattamis, MD1, Dimitra Kyriakopoulou, MD1*, Maria Moraki, MD1*, Dimitrios Kountouras, MD, PhD2* and Nikolaos Alexiou, MD3*

1First Department of Pediatrics, University of Athens, Goudi,Athens, Greece
2Department of Hepatology, “Hygeia” Hospital, Marousi,Athens, Greece
3Department of Gastoenterelogy,Laiko General Hospital, University of Athens, Goudi,Athens, Greece

*signifies non-member of ASH